16-month team-based program to design & lead hematology quality improvement projects.
Apply by Jan 5, 2026 👉 https://ow.ly/zRuN50X4ugg
#Hematology #QI #HealthcareImprovement
16-month team-based program to design & lead hematology quality improvement projects.
Apply by Jan 5, 2026 👉 https://ow.ly/zRuN50X4ugg
#Hematology #QI #HealthcareImprovement
Great food 😋🍲🥘; great hospitality 🏨🏖️🏙️; great selection of topics 🤓🩸
www.hematology.org/meetings/hig...
Great food 😋🍲🥘; great hospitality 🏨🏖️🏙️; great selection of topics 🤓🩸
www.hematology.org/meetings/hig...
Join Dr. Anna Parks for a fascinating talk on aging and blood clots—what you need to know, what science is discovering, and how it could impact your health.
hemostasistoday.com/insight/nbca...
Join Dr. Anna Parks for a fascinating talk on aging and blood clots—what you need to know, what science is discovering, and how it could impact your health.
hemostasistoday.com/insight/nbca...
However, Squid Games S3 and the Gilded Age S3 is tempting me instead...
The struggle is real... 😅
However, Squid Games S3 and the Gilded Age S3 is tempting me instead...
The struggle is real... 😅
www.nytimes.com/2025/06/28/h...
www.nytimes.com/2025/06/28/h...
In acute VTE patients, apixaban therapy led to less clinically-relevant bleeding than rivaroxaban for the first 3 months of therapy. Kudos to Dr Castellucci and colleagues. #COBRRA-VTE
In acute VTE patients, apixaban therapy led to less clinically-relevant bleeding than rivaroxaban for the first 3 months of therapy. Kudos to Dr Castellucci and colleagues. #COBRRA-VTE
#systemsbasedhematology
The team, including @heme-fan.bsky.social and @gbarnesmd.bsky.social recommend addressing this knowledge gap with better patient education resources!
www.rpthjournal.org/article/S247...
#systemsbasedhematology
The team, including @heme-fan.bsky.social and @gbarnesmd.bsky.social recommend addressing this knowledge gap with better patient education resources!
www.rpthjournal.org/article/S247...
The team, including @heme-fan.bsky.social and @gbarnesmd.bsky.social recommend addressing this knowledge gap with better patient education resources!
www.rpthjournal.org/article/S247...
Please share your ideas and topics for the Treating Fairly Recommendations List using the survey below.
hematology.questionpro.com/a/TakeSurvey...
Please share your ideas and topics for the Treating Fairly Recommendations List using the survey below.
hematology.questionpro.com/a/TakeSurvey...
My initial 3 years as a junior faculty was supported by Dr Charles Greenberg. He was always available for questions and I have learnt so much about the business of medicine from him. #ASHKudos
@ash-hematology.bsky.social
@ash-hematology.bsky.social
Personally, I do peruse them to learn about new hematological malignancy drugs. 😀
Personally, I do peruse them to learn about new hematological malignancy drugs. 😀
Free upgrade to first class seat
Great start to the week
#ASHaiku
@ash-hematology.bsky.social
Free upgrade to first class seat
Great start to the week
#ASHaiku
@ash-hematology.bsky.social